Compare IRDM & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRDM | KOD |
|---|---|---|
| Founded | 2000 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.5B |
| IPO Year | N/A | 2018 |
| Metric | IRDM | KOD |
|---|---|---|
| Price | $18.52 | $26.62 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 7 |
| Target Price | ★ $27.60 | $26.57 |
| AVG Volume (30 Days) | ★ 2.7M | 1.1M |
| Earning Date | 02-12-2026 | 11-13-2025 |
| Dividend Yield | ★ 3.33% | N/A |
| EPS Growth | ★ 22.73 | N/A |
| EPS | ★ 1.14 | N/A |
| Revenue | ★ $871,710,000.00 | N/A |
| Revenue This Year | $7.82 | N/A |
| Revenue Next Year | $1.98 | N/A |
| P/E Ratio | $15.85 | ★ N/A |
| Revenue Growth | ★ 7.30 | N/A |
| 52 Week Low | $15.65 | $1.92 |
| 52 Week High | $34.45 | $31.18 |
| Indicator | IRDM | KOD |
|---|---|---|
| Relative Strength Index (RSI) | 58.87 | 53.41 |
| Support Level | $17.94 | $23.92 |
| Resistance Level | $18.76 | $28.11 |
| Average True Range (ATR) | 0.65 | 2.28 |
| MACD | 0.11 | -0.46 |
| Stochastic Oscillator | 76.04 | 35.26 |
Iridium Communications Inc is the commercial provider of communications services offering true globalised coverage, connecting people, organizations and assets to and from anywhere, in real time. The company is a provider of mobile voice and data communications services through a constellation of low earth-orbiting satellites. Iridium's solutions are ideally suited for industries such as maritime, aviation, government/military, emergency/humanitarian services, mining, forestry, oil and gas, heavy equipment, transportation, and utilities. Iridium also provides service to subscribers from the U.S. Department of Defense, as well as other civil and government agencies world-wide. The Company operates in one business segment, providing satellite communications services and products.
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.